Proteasome Inhibitors Induce Death but Activate NF-κB on Endometrial Carcinoma Cell Lines and Primary Culture Explants

This publication has 37 references indexed in Scilit:

• Differential Regulation of Noxa in Normal Melanocytes and Melanoma Cells by Proteasome Inhibition: Therapeutic Implications
  Cancer Research, 2005
• Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma Cells
  Cancer Research, 2005
• Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors
  Oncogene, 2005
• Human T-cell Lymphotropic Virus Type 1 Tax Induction of Biologically Active NF-κB Requires IκB Kinase-1-mediated Phosphorylation of RelA/p65
  Journal of Biological Chemistry, 2004
• IκB Kinase-Independent IκBα Degradation Pathway: Functional NF-κB Activity and Implications for Cancer Therapy
  Molecular and Cellular Biology, 2003
• The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells
  Oncogene, 2003
• NF-κB in cancer: from innocent bystander to major culprit
  Nature Reviews Cancer, 2002
• NF-κB at the crossroads of life and death
  Nature Immunology, 2002
• Aberrant rel/nfkb genes and activity in human cancer
  Oncogene, 1999
• Activators and target genes of Rel/NF-κB transcription factors
  Oncogene, 1999